SVB Leerink Downgrades Moderna (MRNA) to Underperform
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $68.27 -10.83%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
SVB Leerink analyst Mani Foroohar downgraded Moderna (NASDAQ: MRNA) from Market Perform to Underperform with a price target of $93.00 (from $111.00).
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $147.57 yesterday.
You May Also Be Interested In
- JPMorgan Downgrades Jasa Marga Persero (JSMR:IJ) (PTJSF) to Neutral
- Suzhou TFC Optical Communication (300394:CH) PT Lowered to RMB282 at Nomura/Instinet
- Largan Precision Co Ltd. (3008:TT) PT Raised to NT$6,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
